Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology ...
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 3,940,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback